Importance of Efferocytosis in COVID-19 Mortality

Adnan Erol Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, TurkeyCorrespondence: Adnan Erol, Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, Turkey, Email eroladnan@protonmail.comAbstract: COVID-19 is a generally benign coronavirus disease th...

Full description

Bibliographic Details
Main Author: Erol A
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/importance-of-efferocytosis-in-covid-19-mortality-peer-reviewed-fulltext-article-IDR
_version_ 1818690979270492160
author Erol A
author_facet Erol A
author_sort Erol A
collection DOAJ
description Adnan Erol Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, TurkeyCorrespondence: Adnan Erol, Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, Turkey, Email eroladnan@protonmail.comAbstract: COVID-19 is a generally benign coronavirus disease that can spread rapidly, except for those with a group of risk factors. Since the pathogenesis responsible for the severity of the disease has not been clearly revealed, effective treatment alternatives has not been developed. The hallmark of the SARS-CoV-2-infected cells is apoptosis. Apoptotic cells are cleared through a sterile process defined as efferocytosis by professional and nonprofessional phagocytic cells. The disease would be rapidly brought under control in the organism that can achieve effective efferocytosis, which is also a kind of innate immune response. In the risk group, the efferocytic process is defective. With the addition of the apoptotic cell load associated with SARS-COV-2 infection, failure to achieve efferocytosis of dying cells can initiate secondary necrosis, which is a highly destructive process. Uncontrolled inflammation and coagulation abnormalities caused by secondary necrosis reason in various organ failures, lung in particular, which are responsible for the poor prognosis. Following the short and simplified information, this opinion paper aims to present possible treatment options that can control the severity of COVID-19 by detailing the mechanisms that can cause defective efferocytosis.Graphical Abstract: Keywords: COVID-19, SARS-CoV-2, efferocytosis: ADAM17, phosphatidylserine
first_indexed 2024-12-17T12:34:36Z
format Article
id doaj.art-a7b7c7fee2d1413b9a5761f404ad71e2
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-17T12:34:36Z
publishDate 2022-03-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-a7b7c7fee2d1413b9a5761f404ad71e22022-12-21T21:48:23ZengDove Medical PressInfection and Drug Resistance1178-69732022-03-01Volume 15995100773607Importance of Efferocytosis in COVID-19 MortalityErol AAdnan Erol Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, TurkeyCorrespondence: Adnan Erol, Independent Researcher, Not Affiliated to Any Institution, Silivri-Istanbul, Turkey, Email eroladnan@protonmail.comAbstract: COVID-19 is a generally benign coronavirus disease that can spread rapidly, except for those with a group of risk factors. Since the pathogenesis responsible for the severity of the disease has not been clearly revealed, effective treatment alternatives has not been developed. The hallmark of the SARS-CoV-2-infected cells is apoptosis. Apoptotic cells are cleared through a sterile process defined as efferocytosis by professional and nonprofessional phagocytic cells. The disease would be rapidly brought under control in the organism that can achieve effective efferocytosis, which is also a kind of innate immune response. In the risk group, the efferocytic process is defective. With the addition of the apoptotic cell load associated with SARS-COV-2 infection, failure to achieve efferocytosis of dying cells can initiate secondary necrosis, which is a highly destructive process. Uncontrolled inflammation and coagulation abnormalities caused by secondary necrosis reason in various organ failures, lung in particular, which are responsible for the poor prognosis. Following the short and simplified information, this opinion paper aims to present possible treatment options that can control the severity of COVID-19 by detailing the mechanisms that can cause defective efferocytosis.Graphical Abstract: Keywords: COVID-19, SARS-CoV-2, efferocytosis: ADAM17, phosphatidylserinehttps://www.dovepress.com/importance-of-efferocytosis-in-covid-19-mortality-peer-reviewed-fulltext-article-IDRcovid-19sars-cov-2efferocytosis: adam17phosphatidylserine
spellingShingle Erol A
Importance of Efferocytosis in COVID-19 Mortality
Infection and Drug Resistance
covid-19
sars-cov-2
efferocytosis: adam17
phosphatidylserine
title Importance of Efferocytosis in COVID-19 Mortality
title_full Importance of Efferocytosis in COVID-19 Mortality
title_fullStr Importance of Efferocytosis in COVID-19 Mortality
title_full_unstemmed Importance of Efferocytosis in COVID-19 Mortality
title_short Importance of Efferocytosis in COVID-19 Mortality
title_sort importance of efferocytosis in covid 19 mortality
topic covid-19
sars-cov-2
efferocytosis: adam17
phosphatidylserine
url https://www.dovepress.com/importance-of-efferocytosis-in-covid-19-mortality-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT erola importanceofefferocytosisincovid19mortality